Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures.
Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures.
复制标题
基于成瘾医学实践的研究网络（AMNet）：评估工具和质量措施。
DOI：
10.2147/sar.s305972
复制
发表时间：
2021
影响因子：
1.8
通讯作者：
Schwartz RP
中科院分区：
文献类型：
--
作者：
Clarke DE;Ibrahim A;Doty B;Patel S;Gibson D;Pagano A;Thompson L;Goldstein AB;Vocci F;Schwartz RP
人们普遍认识到，需要采取创新方法来解决美国的阿片类药物流行病。解决这一流行病存在许多挑战，包括门诊药物使用治疗实践在实施基于测量的护理（MBC），质量测量系统和循证治疗方面面临的障碍。此外，在这些环境中，临床医生参与研究的机会不足，导致研究成果转化为社区实践的机会减少。为了应对这些挑战，成瘾医学实践为基础的研究网络（AMNet）的开发，以促进MBC在门诊实践中的吸收，通过实施患者报告的评估和护理性能的措施，以改善患者的结果质量。该网络将为门诊医生（不包括阿片类药物治疗计划[OTP]）提供参与未来物质使用障碍治疗研究的机会。AMNet开发的一个关键步骤是选择特定于药物使用的评估工具和护理质量绩效指标，以纳入美国精神病学协会的精神健康患者登记处PsychPRO。使用范围审查和基于多步骤共识的过程来识别、审查和选择阿片类药物使用障碍（OUD）和物质使用障碍（SUD）的候选评估工具和护理质量性能指标。根据基于共识的方法，选择了12种标准化评估工具和3种OUD和SUD的护理质量性能指标，以帮助促进MBC的实施和AMNet参与者的质量改进。这些工具又进一步分为核心工具和可选工具。通过PsychPRO提供一系列经过仔细审查的评估工具和质量措施，AMNet将帮助参与的临床医生系统地接受MBC，并为SUD患者提供循证治疗。此外，AMNet将作为从非OTP门诊成瘾医学实践中的患者和临床医生收集的数据的集中存储库，并作为阿片类药物治疗研究的平台。
The need for innovative approaches to address the opioid epidemic in the United States is widely recognized. Many challenges exist to addressing this epidemic, including the obstacles outpatient substance use treatment practices face in implementing measurement-based care (MBC), quality measurement systems, and evidence-based treatments. Also, there are insufficient opportunities for clinicians in these settings to participate in research, resulting in diminished translation of research findings into community-based practice. To address these challenges, the Addiction Medicine Practice-Based Research Network (AMNet) was developed to facilitate the uptake of MBC in outpatient practices via implementation of patient-reported assessments and quality of care performance measures to improve patient outcomes. This network will offer clinicians in outpatient settings (not incuding opioid treatment programs [OTPs]) the opportunity to participate in future substance use disorder treatment research studies. A key step in the development of AMNet was the selection of substance use-specific assessment tools and quality of care performance measures for incorporation into the American Psychiatric Association’s mental health patient registry, PsychPRO. A scoping review and multi-step consensus-based process were used to identify, review and select candidate assessment tools and quality of care performance measures for opioid use disorders (OUD) and substance use disorders (SUD). Following a consensus-based methodology, 12 standardized assessment tools and 3 quality of care performance measures for OUD and SUD were selected to help facilitate the implementation of MBC and quality improvement for AMNet participants. These tools were further categorized as core and optional. By offering a collection of carefully vetted assessment tools and quality measures through PsychPRO, AMNet will help participating clinicians with the systematic uptake of MBC and delivery of evidence-based treatment for patients with SUD. Also, AMNet will act as a centralized repository of data collected from patients and clinicians in non-OTP outpatient addiction medicine practices and serve as a platform for opioid treatment research.